Families researching acute ischemic stroke treatment often come across the comparison of thrombectomy vs tPA and assume they must choose one over the other. In practice, these are two different tools with different mechanisms, and in many cases they are used in sequence rather than as competing alternatives. This article compares how each treatment generally works, what clinicians typically weigh when considering them, and why the choice — or combination — depends on the individual patient.
What Is tPA and How Does It Work?
tPA, or tissue plasminogen activator (also referred to as alteplase, with tenecteplase used in some settings), is a clot-dissolving medication delivered through an intravenous line. This approach is often called intravenous thrombolysis, or IVT. Rather than physically removing a clot, tPA works pharmacologically to break down the fibrin structure holding the clot together, gradually restoring blood flow as the clot dissolves. It is generally considered within a defined early time window after symptom onset and requires screening to rule out contraindications such as active bleeding risk. Dosing and administration are determined entirely by a treating physician and are not addressed in this article.
What Is Mechanical Thrombectomy and How Does It Differ?
Mechanical thrombectomy, sometimes referred to in this comparison as a device-based or "clot buster vs device" approach, is a catheter-based procedure, often referred to as endovascular therapy or EVT. Instead of dissolving the clot chemically, a specialist guides a catheter to the blockage and uses a device such as a stent retriever to physically capture and remove it. This approach is generally considered for large vessel occlusions, where a clot may be too large for medication alone to clear effectively, and it can be considered within a longer time window than IVT in appropriately selected patients based on imaging.
Typical Advantages and Considerations of Each Approach
Each option carries its own general considerations. IVT with tPA can typically be started quickly once imaging rules out bleeding, does not require a specialized catheterization suite, and works throughout the smaller blood vessels that a catheter cannot easily reach. However, it may be less effective against large, firm clots typical of large vessel occlusion, and it carries bleeding-related contraindications that must be screened for. Mechanical thrombectomy can directly address large vessel occlusions and may be considered later in the time course when appropriate imaging criteria are met, but it requires a specialized team, catheterization equipment, and transfer to a capable stroke center if the patient is not already there. Neither approach is universally preferable; each has a role depending on clot location, size, timing, and patient-specific factors.
Why Are IVT and EVT Often Used Together?
Rather than framing thrombectomy vs tPA as a strict either/or decision, many stroke centers use a combined strategy commonly called bridging therapy, describing IVT plus EVT. In this approach, tPA may be administered first, as it can be started rapidly, while the patient is simultaneously prepared for or transferred toward a thrombectomy procedure if a large vessel occlusion is confirmed. The intent is not to compare which treatment is superior but to use each therapy's respective strengths within the same care pathway. A device such as a stent retriever from INVAMED's neurovascular interventions category may be used during the endovascular portion of this combined approach when appropriate.
Can a patient receive thrombectomy without ever having tPA?
Yes. Some patients have contraindications to IVT, arrive outside the tPA time window, or are found to have a large vessel occlusion for which thrombectomy is considered the more directly applicable option. Treatment pathways are individualized rather than fixed.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.